SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to positive Phase 3 trial results for its Duchenne muscular dystrophy (DMD) treatment, reigniting hopes for FDA approval. Community members are celebrating the potential for a first-in-class therapy and discussing the possibility of a short squeeze, with some analysts raising price targets significantly.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana's recent price surge has sparked heated debate, with many questioning the company's valuation amid high debt and a challenged used car market. Community chatter revolves around whether the stock is primed for a correction or if it will continue its upward momentum, possibly driven by short squeezes and speculative trading. Bears cite fundamental concerns and potential market manipulation, while bulls point to technical indicators and analyst upgrades.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as discussions revolve around its potential role in AI infrastructure, particularly after Marvell's acquisition of Celestial AI, a company using POET's technology. The community is analyzing potential impacts on POET's revenue and partnerships, speculating on future purchase orders or even a potential acquisition. Bullish sentiment is fueled by the belief that POET's technology is essential for next-generation data centers and AI applications.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending as investors await news regarding the NASA Lunar Terrain Vehicle (LTV) contract award, a potential game-changer for the company. Community chatter also highlights a recent insider buy and speculation around new contracts and partnerships. Despite some skepticism, optimism persists around future lunar missions and the company's growth potential in the space sector.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid ongoing speculation and bidding wars with Warner Bros. Discovery ($WBD), with investors assessing the potential impact of a deal. The community is actively debating whether acquiring $WBD would be a positive move, and whether the company should focus on organic growth instead.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amidst community excitement surrounding potential catalysts like Michael Burry's promised GME story and anticipation for upcoming earnings, with sentiment boosted by a recent significant buy order. Despite some skepticism about immediate price movement and ongoing manipulation concerns, the community remains focused on the company's fundamentals, including its cash position and transformation strategy. Discussions also revolve around warrants and potential for a squeeze, as well as the possible influence of key figures like Ryan Cohen.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as the community discusses a new CEO appointment and what it signals for the company's strategic direction, with potential implications for partnerships or a buyout. Community members are analyzing the new CEO's background and compensation package, speculating on the timing of upcoming data releases, and assessing the impact on the company's future. The conversation also includes discussion around a potential price target increase by Piper Sandler.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending amid discussions about its potential for continued growth and government contracts related to drone technology. The community is actively debating market manipulation, short positions, and potential price movements, while highlighting the company's strategic positioning in defense and border security. Investors are weighing the impact of recent contracts and acquisitions on ONDS's future performance.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

SERV is trending as the community discusses the potential impact of a possible executive order from the Trump administration to bolster the robotics industry. Chatter revolves around the stock's potential to fill gaps and reach higher price levels. Some investors are expressing confidence in the company's long-term prospects and partnerships.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a recent analyst upgrade from Jefferies, with a significantly increased price target fueling speculation. The community is buzzing about potential buyout scenarios and the implications of recent institutional activity, including Tang Capital's increased stake. Broader discussions involve the company's growth potential, pipeline prospects, and ongoing speculation about a potential acquisition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New York State Common Retirement Fund Increases Position in Vericel Corporation $VCEL

New York State Common Retirement Fund increased its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 3.3% in the second quarter, according to its most recent filing with the Securities...

Vericel Corporation $VCEL Shares Sold by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P trimmed its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 2.4% during the second quarter, according to the company in its most recent filing with the...

Vericel Corporation (NASDAQ:VCEL) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Vericel Corporation (NASDAQ:VCEL - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven analysts that are presently covering the stock, MarketBeat...

Franklin Resources Inc. Acquires 64,849 Shares of Vericel Corporation $VCEL

Franklin Resources Inc. increased its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 23.8% in the second quarter, according to the company in its most recent Form 13F filing with the...

Vericel (NASDAQ:VCEL) Trading Down 4.1% - Should You Sell?

Vericel (NASDAQ:VCEL) Shares Down 4.1% - Here's What Happened...

Geode Capital Management LLC Increases Stake in Vericel Corporation $VCEL

Geode Capital Management LLC lifted its position in Vericel Corporation (NASDAQ:VCEL - Free Report) by 3.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and...

Vericel Corporation $VCEL Shares Purchased by CenterBook Partners LP

CenterBook Partners LP raised its stake in Vericel Corporation (NASDAQ:VCEL - Free Report) by 242.7% during the second quarter, according to the company in its most recent 13F filing with the...

Vericel (NASDAQ:VCEL) Stock Rating Lowered by Zacks Research

Zacks Research downgraded shares of Vericel from a "strong-buy" rating to a "hold" rating in a report on Wednesday...

TimesSquare Capital Management LLC Purchases 90,924 Shares of Vericel Corporation $VCEL

TimesSquare Capital Management LLC lifted its position in shares of Vericel Corporation (NASDAQ:VCEL - Free Report) by 13.9% in the 2nd quarter, according to its most recent 13F filing with the SEC...

Vericel's (VCEL) "Buy" Rating Reaffirmed at Truist Financial

Truist Financial reissued a "buy" rating and issued a $50.00 price target (up previously from $41.00) on shares of Vericel in a research note on Monday...

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Current Price	$37.84
Prev Close	$37.65
Open	$37.77
Dividend Yield	0.00%
50-Day Moving Average	$35.95
Beta	1.26
Avg. Volume	698,916.79
PE Ratio	156.35

52-Week High	$63.00
52-Week Low	$29.24
Market Capitalization	$1.9B
EPS (Annual)	$0.2005
Price to Book	5.91
Revenue Per Employee	$664,493.00
Enterprise Value/EBITDA	N/A

VCEL
Vericel Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VCEL News

VCELVericel Corp